The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America.
Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. The companies operating in this region have been focusing on new product developments, mergers and acquisitions in order to establish their position in this highly competitive and rapidly growing market.
The report has profiled the leading players of this market along with the strategies (new product launches, partnerships, and joint ventures) done adopted by them to sustain and strengthen their position in the European orthobiologics market. The key players in the operating in the European orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
